Gender differences in the relationship between white matter organization and adolescent substance use disorders.
Few studies have focused on the neurobiological correlates of adolescent-onset substance use disorders (SUDs), particularly with respect to white matter development and organization. This study investigated microstructural white matter characteristics associated with SUDs during the adolescent developmental period. Twenty-four case adolescents (ages 14-18) entering treatment for SUDs and 12 sex- and age-matched control adolescents with no psychopathology were compared. Diffusion tensor imaging data were collected and analyzed using the whole-brain tract-based spatial statistics (TBSS) method. In order to comprehensively characterize diffusivity characteristics, we first studied fractional anisotropy (FA), and within regions that differed in FA, other indicators of microstructure, including the axial diffusivity (AD), radial diffusivity (RD), and mean diffusivity (MD). A large cluster of significantly lower FA values was found in cases compared to controls in the superior longitudinal fasciculus (SLF). Within this cluster, AD and RD were also significantly different between the groups, while MD was not significantly different. For FA, a significant group by sex interaction was found; females with SUD exhibited lower FA than males with SUD, while control females exhibited higher FA than control males. These results indicated significantly lower white matter integrity in the superior longitudinal fasciculus region of association cortex, and assessed using multiple indicators of diffusion. These findings suggest that the disruption of normal white matter development due to substance exposure may be more severe in females than in males.
Thatcher
Dawn L
DL
University of Pittsburgh, School of Medicine, Department of Psychiatry, Pittsburgh, PA 15213, USA. thatcherdl@upmc.edu
Pajtek
Stefan
S
Chung
Tammy
T
Terwilliger
Robert A
RA
Clark
Duncan B
DB
D000293:Adolescent; D016880:Anisotropy; D016022:Case-Control Studies; D002540:Cerebral Cortex / Q000473:pathology* / Q000648:ultrastructure; D017831:Diagnosis, Dual (Psychiatry); D038524:Diffusion Magnetic Resonance Imaging; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000473:pathology / Q000523:psychology; D015999:Multivariate Analysis; D009186:Myelin Sheath / Q000473:pathology; D011569:Psychiatric Status Rating Scales; D012727:Sex Characteristics; D019966:Substance-Related Disorders / Q000473:pathology*
Neuroimage. 2008 Jun;41(2):223-32
18395471
IEEE Trans Med Imaging. 1999 Aug;18(8):712-21
10534053
J Stud Alcohol Suppl. 2002 Mar;(14):54-70
12022730
Psychiatry Res. 2008 May 30;163(1):40-51
18356027
Hum Brain Mapp. 2002 Nov;17(3):143-55
12391568
Neuroimage. 2004;23 Suppl 1:S208-19
15501092
Radiology. 2001 Sep;220(3):611-7
11526257
Biol Psychiatry. 2002 Jun 1;51(11):890-5
12022962
Drug Alcohol Depend. 2000 May 1;59(2):173-6
10891630
J Psychiatr Res. 2009 Jan;43(3):189-204
19111160
J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8
9204677
Neuroimage. 2007 Apr 1;35(2):501-10
17258911
Alcohol Clin Exp Res. 2008 Mar;32(3):395-404
18241319
Alcohol Clin Exp Res. 2008 Mar;32(3):386-94
18302722
Neurosci Biobehav Rev. 2000 Jun;24(4):417-63
10817843
Neuroimage. 2009 Jan 1;44(1):83-98
18501637
Alcohol Clin Exp Res. 2000 Aug;24(8):1214-21
10968660
Neuropsychopharmacology. 2005 Feb;30(2):423-32
15562292
Neuroimage. 2008 Jan 1;39(1):52-61
17919933
Addict Biol. 2009 Sep;14(4):457-68
19650817
Psychopharmacology (Berl). 2007 Oct;194(2):173-83
17558500
Alcohol Clin Exp Res. 2000 Nov;24(11):1712-23
11104119
Neuroreport. 2006 Sep 18;17(13):1427-31
16932152
Ann N Y Acad Sci. 2005 Dec;1064:184-92
16394156
J Am Acad Child Adolesc Psychiatry. 2002 May;41(5):546-54
12014787
J Am Acad Child Adolesc Psychiatry. 2001 Sep;40(9):1012-20
11556624
Neuroimage. 2007 Jan 1;34(1):243-52
17070704
Neuroimage. 2006 Jul 15;31(4):1487-505
16624579
Neuropsychopharmacology. 2005 Mar;30(3):610-7
15637640
Neuroimage. 2008 Jul 1;41(3):1067-74
18424082
Harm Reduct J. 2006 May 09;3:17
16684342
Magn Reson Med. 2003 Nov;50(5):1077-88
14587019
Psychiatry Res. 2009 Sep 30;173(3):228-37
19699064
Alcohol Alcohol. 2003 Jan-Feb;38(1):71-8
12554612
Ann N Y Acad Sci. 2004 Jun;1021:77-85
15251877
Am J Psychiatry. 2003 Jun;160(6):1041-52
12777258
Neurosci Biobehav Rev. 2006;30(6):718-29
16887188
J Am Acad Child Adolesc Psychiatry. 1997 Sep;36(9):1195-203
9291720
J Stud Alcohol. 1995 Nov;56(6):672-80
8558899
Alcohol Clin Exp Res. 2009 Jul;33(7):1278-85
19389185
Addict Behav. 1995 Mar-Apr;20(2):233-41
7484317
Cereb Cortex. 2005 Jun;15(6):854-69
15590909
Hum Brain Mapp. 2009 Sep;30(9):2757-65
19107752
Int J Neuropsychopharmacol. 2006 Apr;9(2):147-53
16004619
Alcohol Clin Exp Res. 2008 Mar;32(3):375-85
18241320